MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

LeMaitre Vascular Company Profile (NASDAQ:LMAT)

Consensus Ratings for LeMaitre Vascular (NASDAQ:LMAT) (?)
Ratings Breakdown: 8 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $17.56 (23.07% upside)

Analysts' Ratings History for LeMaitre Vascular (NASDAQ:LMAT)
Show:
DateFirmActionRatingPrice TargetActions
5/3/2016Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Canaccord GenuityReiterated RatingBuy$6.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Roth CapitalBoost Price TargetBuy$18.00 -> $18.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2016Barrington ResearchReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/8/2016SidotiUpgradeNeutral -> Buy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Dougherty & CoBoost Price TargetBuy$16.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2015Benchmark Co.Boost Price Target$15.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2015Stifel NicolausBoost Price TargetBuy$14.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for LeMaitre Vascular (NASDAQ:LMAT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/26/2016        
5/2/2016Q1$0.10$0.11ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2016Q415$0.09$0.13$20.10 million$20.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q3$0.08$0.11ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2015Q2$0.07$0.10ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2015Q115$0.05$0.08$17.76 million$18.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2015Q314$0.07$0.11$18.90 million$18.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2014Q3$0.06$0.05ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q214$0.05$0.08$17.50 million$18.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2014Q1$0.02$0.01ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2014Q4$0.05$0.05ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q313$0.04$0.05$15.22 million$15.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for LeMaitre Vascular (NASDAQ:LMAT)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.09$0.10$0.10
Q2 20162$0.11$0.11$0.11
Q3 20162$0.12$0.13$0.13
Q4 20164$0.11$0.14$0.13
(Data provided by Zacks Investment Research)
Dividend History for LeMaitre Vascular (NASDAQ:LMAT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/4/2016quarterly$0.051.12%5/23/20165/25/20166/8/2016Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016quarterly$0.051.19%3/17/20163/21/20164/4/2016Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015quarterly$0.041.11%11/18/201511/20/201512/4/2015Tweet This Announcement  Share This Announcement on StockTwits
7/29/2015quarterly$0.041.25%8/18/20158/20/20159/3/2015Tweet This Announcement  Share This Announcement on StockTwits
4/29/2015quarterly$0.041.85%5/20/20155/22/20156/5/2015Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015quarterly$0.042.03%3/18/20153/20/20154/3/2015Tweet This Announcement  Share This Announcement on StockTwits
10/28/2014quarterly$0.041.93%11/18/201411/20/201412/4/2014Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014quarterly$0.041.73%8/19/20148/21/20149/4/2014Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014quarterly$0.041.71%5/20/20145/22/20146/5/2014Tweet This Announcement  Share This Announcement on StockTwits
2/26/2014quarterly$0.041.75%3/18/20143/20/20144/3/2014Tweet This Announcement  Share This Announcement on StockTwits
10/31/2013quarterly$0.031.49%11/18/201311/20/201312/4/2013Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013quarterly$0.031.73%8/19/20138/21/20139/4/2013Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013quarterly$0.031.98%5/20/20135/22/20136/5/2013Tweet This Announcement  Share This Announcement on StockTwits
2/27/2013quarterly$0.031.92%3/18/20133/20/20134/3/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for LeMaitre Vascular (NASDAQ:LMAT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/8/2016George W LemaitreCEOSell19,189$15.01$288,026.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2016George W LemaitreCEOSell9,100$15.02$136,682.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2016George W LemaitreCEOSell900$15.06$13,554.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2016Peter R GebauerInsiderSell6,310$14.96$94,397.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2016Lawrence J JasinskiDirectorSell4,924$14.99$73,810.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2016Trent G KamkeInsiderSell2,510$15.00$37,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Lawrence J JasinskiDirectorSell6,326$15.30$96,787.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Trent G KamkeInsiderSell1,524$15.25$23,241.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2016Trent G KamkeInsiderSell16,465$15.02$247,304.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016George W LemaitreCEOSell2,944$15.23$44,837.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Trent G KamkeInsiderSell2,400$15.51$37,224.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016George W LemaitreCEOSell1,740$15.49$26,952.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016George W LemaitreCEOSell7,451$15.45$115,117.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2016George W LemaitreCEOSell110,189$16.17$1,781,756.13View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016David B RobertsDirectorSell17,064$15.89$271,146.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2016Trent G KamkeInsiderSell3,327$16.10$53,564.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/18/2016David B RobertsDirectorSell1,766$16.10$28,432.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016David B RobertsDirectorSell17,444$15.99$278,929.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2016David B RobertsDirectorSell2,690$15.91$42,797.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/14/2016David B. RobertsDirectorSell12,867$15.85$203,941.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2016David B RobertsDirectorSell27,490$15.68$431,043.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2016David B RobertsDirectorSell2,743$15.51$42,543.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2015Joseph P. Pellegrino, Jr.CFOSell14,348$16.01$229,711.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2015Peter R. GebauerinsiderSell12,816$15.53$199,032.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015Peter R. GebauerinsiderSell37,184$15.73$584,904.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2015David B. RobertsDirectorSell10,000$15.96$159,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2015Cornelia W LemaitreDirectorSell41,135$15.61$642,117.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/23/2015George W. LemaitreCEOSell65,052$15.63$1,016,762.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/23/2015Joseph P. Pellegrino, Jr.CFOSell45,840$15.57$713,728.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/23/2015Peter R. GebauerinsiderSell11,971$15.31$183,276.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2015David B. RobertsDirectorSell10,000$14.73$147,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2015Peter R. GebauerinsiderSell19,900$14.40$286,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2015George W LemaitreCEOSell30,000$14.15$424,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2015Lawrence J. JasinskiDirectorSell7,500$13.57$101,775.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015George W. LemaitreCEOSell57,844$13.80$798,247.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/9/2015George W. LemaitreCEOSell7,524$13.70$103,078.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015George W. LemaitreCEOSell39,000$13.83$539,370.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2015George W. LemaitreCEOSell16,190$14.55$235,564.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2015Peter R. GebauerinsiderSell44,315$13.97$619,080.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/25/2015Peter R. GebauerinsiderSell5,441$13.91$75,684.31View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2015George W. LemaitreCEOSell46,391$14.37$666,638.67View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2015George W. LemaitreCEOSell49,559$13.96$691,843.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/31/2015Peter R. GebauerinsiderSell10,465$13.49$141,172.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2015George W. LemaitreCEOSell28,700$13.66$392,042.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2015Peter R. GebauerinsiderSell15,978$13.53$216,182.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2015David B RobertsDirectorSell12,000$13.58$162,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2015Peter R. GebauerinsiderSell4,022$14.24$57,273.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015George W LemaitreCEOSell33,059$13.41$443,321.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2015Peter R GebauerInsiderSell10,000$10.12$101,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2015George W LemaitreCEOSell20,132$10.01$201,521.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2015David B RobertsDirectorSell15,000$10.31$154,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2015George W LemaitreCEOSell70,984$9.72$689,964.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2015David B RobertsDirectorSell11,000$9.27$101,970.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2015Peter R GebauerInsiderSell15,332$8.99$137,834.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/16/2015Cornelia W LemaitreDirectorSell17,100$8.55$146,205.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2015Cornelia W LemaitreDirectorSell6,707$8.42$56,472.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2015Cornelia W LemaitreDirectorSell819$8.37$6,855.03View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/30/2015Cornelia W LemaitreDirectorSell31$8.36$259.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2015Cornelia W LemaitreDirectorSell3,678$8.33$30,637.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2015Cornelia W LemaitreDirectorSell3,373$8.33$28,097.09View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Cornelia W LemaitreDirectorSell26,026$8.21$213,673.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2015Cornelia W LemaitreDirectorSell5,601$8.03$44,976.03View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Peter R GebauerInsiderSell10,000$8.15$81,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Peter R GebauerInsiderSell7,200$8.15$58,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2015Cornelia W LemaitreDirectorSell6,065$8.20$49,733.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015David B RobertsDirectorSell12,000$7.65$91,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2015Peter R GebauerInsiderSell16,919$7.91$133,829.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2015George W LemaitreCEOSell3,486$7.85$27,365.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2015Peter R GebauerInsiderSell1,800$7.90$14,220.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015George W LemaitreCEOSell18,447$7.74$142,779.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015David B RobertsDirectorSell7,000$7.31$51,170.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/30/2014George W LemaitreCEOSell18,067$7.58$136,947.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/29/2014George W LemaitreCEOSell5,058$7.59$38,390.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/26/2014George W LemaitreCEOSell6,693$7.53$50,398.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/24/2014George W LemaitreCEOSell2,900$7.60$22,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2014George W LemaitreCEOSell1,117$7.40$8,265.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014David B RobertsDirectorSell3,000$7.36$22,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014George W LemaitreCEOSell1,794$7.40$13,275.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/28/2014George W LemaitreCEOSell42,641$7.40$315,543.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2014George W LemaitreCEOSell613$7.30$4,474.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014Trent G KamkeInsiderSell1,100$7.15$7,865.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2014George W LemaitreCEOSell28,286$7.07$199,982.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014David B RobertsPresidentSell3,500$7.03$24,605.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014George W LemaitreCEOSell23,758$7.14$169,632.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014George W LemaitreCEOSell29,966$7.10$212,758.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2014Lawrence J JasinskiDirectorSell3,750$7.14$26,775.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/25/2014Cornelia W LemaitreDirectorSell4,700$8.32$39,104.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2014David RobertsPresidentSell3,000$7.95$23,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2014Russell HaysDirectorSell15,000$8.07$121,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2014Cornelia LemaitreDirectorSell6,950$8.15$56,642.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2014Trent KamkeInsiderSell1,278$8.18$10,454.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2014Cornelia LemaitreDirectorSell12,845$8.29$106,485.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/23/2014Cornelia LemaitreDirectorSell3,900$8.24$32,136.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2013David B RobertsDirectorSell2,000$7.96$15,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2013Cornelia W LemaitreDirectorSell20,000$7.88$157,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/25/2013Cornelia W LemaitreDirectorSell20,000$7.38$147,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2013Joseph P Pellegrino JrCFOSell25,000$6.86$171,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013David B RobertsDirectorSell6,500$6.90$44,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Cornelia W LemaitreDirectorSell7,500$7.00$52,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2013Trent G KamkeInsiderSell2,000$6.90$13,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2013Trent G KamkeInsiderSell2,000$6.83$13,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Russell D HaysDirectorSell15,000$6.78$101,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2013David B RobertsDirectorSell12,403$6.85$84,960.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2013Cornelia W LemaitreDirectorSell2,500$7.00$17,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/26/2013David B RobertsDirectorSell9,100$6.77$61,607.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2013David B RobertsDirectorSell2,100$6.75$14,175.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2013Robert V LindenVPSell9,383$6.45$60,520.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/30/2013Cornelia W LemaitreDirectorSell10,000$6.50$65,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2012Cornelia W LemaitreDirectorSell2,699$6.25$16,868.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/10/2012George D LemaitreDirectorSell5,862$6.45$37,809.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for LeMaitre Vascular (NASDAQ:LMAT)
DateHeadline
07/01/16 07:47 AMMyriad Genetics: Study Data Drives Growth, Competition Rife
06/30/16 07:52 AMWere Analysts Bullish LeMaitre Vascular Inc (NASDAQ:LMAT) This Week? - Press Telegraph
06/29/16 07:12 AMBruker Poised on Product Launches amid Near-Term Risks -
06/27/16 09:19 AMLeMaitre Vascular, Inc. (NASDAQ:LMAT) Quarterly Dividend Payout At $0 Millions - Stocks Daily
06/24/16 07:36 AMFDA Okays Trial for Medtronic's MRI-Guided Epilepsy Device
06/21/16 08:32 AMQiagen's Q1 Results Hit by Currency, Competition Rife -
06/20/16 06:55 AMThis Weeks Broker Views For LeMaitre Vascular, Inc. (LMAT) - Fiscal Standard
06/16/16 03:49 PMLeMaitre Vascular to Present at the East Coast IDEAS Investor Conference on June 28, 2016 - [at noodls] - BURLINGTON, Mass., June 16, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President will present at the East Coast IDEAS Investor Conference on Tuesday, ...
06/14/16 09:45 AMNew Broker Ratings For LeMaitre Vascular, Inc. (LMAT) - FTSE News
06/10/16 05:10 PMLeMaitre Vascular, Inc. (NASDAQ:LMAT) Holds $27.451 In Cash And Short-Term Investments - Stocks Daily
06/07/16 03:17 PMLEMAITRE VASCULAR INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/06/16 08:40 AMAbaxis (ABAX): Solid Veterinary Show Despite Global Hiccups
06/06/16 06:40 AMMead Johnson: Strong Q1 on Overseas Growth & Strategies -
06/02/16 07:50 AMStock Review and Earnings Check on LeMaitre Vascular, Inc. (NASDAQ:LMAT) - HNN - Stock Review and Earnings Check on LeMaitre Vascular, Inc. (NASDAQ:LMAT)HNNCurrently, sell-side analysts are expecting LeMaitre Vascular, Inc. (NASDAQ:LMAT) to report quarterly EPS of $0.11. The company's next earnings report is expected to be published on or around 2016-07-26 for the period ending on 2016-06-30. The company ...and more »
05/31/16 08:08 AMShare Rating Focus on LeMaitre Vascular, Inc. (NASDAQ:LMAT) - HNN - Share Rating Focus on LeMaitre Vascular, Inc. (NASDAQ:LMAT)HNNPresently, Wall Street analysts have given a consensus stock rating of 1 on shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT). Covering analysts will typically provide Buy, Sell, or Hold recommendations based on extensive research. This consensus number ...and more »
05/31/16 08:08 AMStock Paining Investors: LeMaitre Vascular, Inc. (NASDAQ:LMAT) - HNN - Stock Paining Investors: LeMaitre Vascular, Inc. (NASDAQ:LMAT)HNNLast year, their EPS growth was LeMaitre Vascular, Inc. (NASDAQ:LMAT) while their EPS growth over the past five years is 2.60%. Analysts are predicting LeMaitre Vascular, Inc. (NASDAQ:LMAT)'s stock to grow 19.38% over the next year and 18.50% over ...and more »
05/28/16 12:54 PMLeMaitre Vascular Enters Oversold Territory (LMAT) - A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday, shares of LeMaitre Vascular Inc (NASDAQ:LMAT) entered into oversold territory, hitting an RSI reading of 27.4, after changing hands as low as $13.75 per share.
05/26/16 12:57 PMEarnings Review and Stock Rundown for LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Wall Street Hints and News - Earnings Review and Stock Rundown for LeMaitre Vascular, Inc. (NASDAQ:LMAT)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting LeMaitre Vascular, Inc. (NASDAQ:LMAT) to ...and more »
05/24/16 01:01 PMAfter Last Week What Do Analysts Think Of LeMaitre Vascular, Inc. (LMAT) - Share Trading News - After Last Week What Do Analysts Think Of LeMaitre Vascular, Inc. (LMAT)Share Trading News05/16/2014 – LeMaitre Vascular, Inc. was downgraded to “hold” by analysts at TheStreet. The share price of LeMaitre Vascular, Inc. (LMAT) was up +0.67% during the last trading session, with a day high of 15.08. 41526 shares were traded on LeMaitre ...and more »
05/24/16 07:25 AMGenomic Health (GHDX): Q1 Results Strong, Costs Escalate -
05/21/16 12:23 PMLeMaitre Vascular, Inc. (NASDAQ:LMAT) One-Year Price Projection At $17.25 - Investor Newswire - LeMaitre Vascular, Inc. (NASDAQ:LMAT) One-Year Price Projection At $17.25Investor NewswireSell-side analysts are certain on the prospect of LeMaitre Vascular, Inc. (NASDAQ:LMAT) stock. As of 2016-05-19, the stock ABR stands at 1. This type of rating states that whenever a stock has a score of 5, investors should avoid investing in such stocks.and more »
05/21/16 12:23 PMLeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for May 23, 2016 - Nasdaq - LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for May 23, 2016NasdaqLeMaitre Vascular, Inc. ( LMAT ) will begin trading ex-dividend on May 23, 2016. A cash dividend payment of $0.045 per share is scheduled to be paid on June 08, 2016. Shareholders who purchased LMAT prior to the ex-dividend date are eligible for the ...Revenue Update on LeMaitre Vascular Inc(NASDAQ:LMAT)Trade CallsLemaitre Vascular Inc (LMAT) Files Form 4 Insider Selling : Trent G Kamke Sells 2400 SharesMarket DigestThe Insider and Chairman and CEO of LeMaitre Vascular Inc (NASDAQ:LMAT), George Lemaitre, Sold 2944 SharesFranklin IndependentRisers & Fallers -Share Trading News -Wall Street Hints and Newsall 10 news articles »
05/19/16 12:23 PMRevenue Update on LeMaitre Vascular Inc(NASDAQ:LMAT) - Trade Calls - Revenue Update on LeMaitre Vascular Inc(NASDAQ:LMAT)Trade CallsLeMaitre Vascular Inc(NASDAQ:LMAT) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 2, 2016. Company reported revenue of $20.26M. Analysts estimated a revenue of $20.20M. Earnings per ...LeMaitre Vascular, Inc. (LMAT) - Broker UpdateRisers & FallersThe Insider and Chairman and CEO of LeMaitre Vascular Inc (NASDAQ:LMAT), George Lemaitre, Sold 2944 SharesFranklin IndependentWhat Did This CEO Just Do with Personal Shares of Lemaitre Vascular (NASDAQ: LMAT)?Analyst RatingsGlobeNewswire (press release)all 5 news articles »
05/18/16 03:02 PMLeMaitre Vascular to Participate in the Benchmark One-on-One Conference on June 2, 2016 - [at noodls] - BURLINGTON, Mass., May 18, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will participate in the Benchmark Company, LLC, One-on-One Investor ...
05/17/16 01:21 PMLemaitre Vascular Incorporated (NASDAQ:LMAT) Sellers Increased By 4.05% Their Shorts - Wall Street Hints and News - Lemaitre Vascular Incorporated (NASDAQ:LMAT) Sellers Increased By 4.05% Their ShortsWall Street Hints and NewsThe short interest to Lemaitre Vascular Incorporated's float is 6.56%. The stock decreased 0.26% or $0.04 on May 13, hitting $15.46. LeMaitre Vascular Inc (NASDAQ:LMAT) has risen 22.99% since October 8, 2015 and is uptrending. It has outperformed by ...
05/15/16 06:44 AMLeMaitre Vascular, Inc. (NASDAQ:LMAT) One-Year Mean Price Target At $17.25 - Investor Newswire - LeMaitre Vascular, Inc. (NASDAQ:LMAT) One-Year Mean Price Target At $17.25Investor NewswireSell-side analysts are confident on the future outlook of LeMaitre Vascular, Inc. (NASDAQ:LMAT) stock. As of 2016-05-13, the stock has an ABR of 1 rating, where number 5 denotes a Strong Sell and 1 Strong Buy. The ABR is reached on the basis of ...and more »
05/08/16 06:25 AMLemaitre Vascular Incorporated (NASDAQ:LMAT) Shorted Shares Increased By 1.13% - B.O.D.Y Confidential - Lemaitre Vascular Incorporated (NASDAQ:LMAT) Shorted Shares Increased By 1.13%B.O.D.Y ConfidentialThe short interest to Lemaitre Vascular Incorporated's float is 6.3%. The stock decreased 1.36% or $0.22 during the last trading session, hitting $15.95. About 72,075 shares traded hands. LeMaitre Vascular Inc (NASDAQ:LMAT) has risen 29.36% since ...
05/07/16 06:29 AMLeMaitre Vascular, Inc. (LMAT) Updated Broker Price Targets - Roth Capital now has a "Buy" rating and a $18.50 target price on the stock. The consensus estimate for LeMaitre Vascular's Q3 2016 earnings is $0.12 per share. Other equities research analysts have also recently issued research reports about the company.
05/06/16 12:30 PMLEMAITRE VASCULAR INC Files SEC form 10-Q, Quarterly Report -
05/06/16 06:52 AMLeMaitre Vascular, Inc. (NASDAQ:LMAT) Basic Consolidated EPS At $0.4367 - Investor Newswire - LeMaitre Vascular, Inc. (NASDAQ:LMAT) Basic Consolidated EPS At $0.4367Investor NewswireThe basic EPS generating from continuing operations as announced by LeMaitre Vascular, Inc. (NASDAQ:LMAT) for the period ended 2015-12-31 was $0.4367. For the quarter ended 2015-12-31, this number was $0.4367. For any specified firm's shares ...Zacks Investment Research Upgrades LeMaitre Vascular Inc (LMAT) to BuyWeb Breaking NewsEarnings Outlook on LeMaitre Vascular, Inc. (NASDAQ:LMAT)B.O.D.Y ConfidentialLeMaitre Vascular, Inc. (NASDAQ:LMAT): Quick Look at Company EarningsNews Tribuneall 10 news articles »
05/05/16 03:05 PMJohn A. Roush Joins the Advanced Energy Board of Directors - [GlobeNewswire] - FORT COLLINS, Colo., May 05, 2016-- Advanced Energy Industries, Inc. today announced that John A. Roush, the chief executive officer of GSI Group, Inc., a leading global supplier of precision photonic ...
05/04/16 05:46 AMAverage Analyst Rating for LeMaitre Vascular, Inc. (NASDAQ:LMAT) - B.O.D.Y Confidential - Average Analyst Rating for LeMaitre Vascular, Inc. (NASDAQ:LMAT)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 1 on LeMaitre Vascular, Inc. (NASDAQ:LMAT) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
05/02/16 04:47 PMLeMaitre tops Street 1Q forecasts -
05/02/16 04:00 PMLeMaitre Vascular Inc Earnings Call scheduled for 5:00 pm ET today -
05/02/16 03:30 PMLeMaitre Q1 2016 Sales $20.3mm (+7%), Op. Inc. $3.3mm (+43%) - [at noodls] - BURLINGTON, Mass., May 02, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, today reported Q1 2016 results, announced a $0.045/share dividend and provided ...
05/02/16 03:27 PMLEMAITRE VASCULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh -
05/02/16 03:27 PM4:27 pm Lemaitre Vascular beats by $0.01 on in-line rev; guides Q2 rev in-line; raises FY16 rev guidance -
05/02/16 06:07 AMQ1 2016 LeMaitre Vascular Inc Earnings Release - After Market Close -
04/30/16 06:43 AMLeMaitre Vascular, Inc. (NASDAQ:LMAT) ABR of 1 - Investor Newswire - LeMaitre Vascular, Inc. (NASDAQ:LMAT) ABR of 1Investor NewswireAnalysts have a buy call on LeMaitre Vascular, Inc. (NASDAQ:LMAT) stock. As of 2016-04-28, the stock has an ABR of 1. This rating comes on a scale of 1-5, where one makes a strong buy call, and 3 indicates Strong Sell. This ABR computation is done on ...and more »
04/27/16 07:51 AMHow Analysts Feel About LeMaitre Vascular Inc (NASDAQ:LMAT)? - The Post - How Analysts Feel About LeMaitre Vascular Inc (NASDAQ:LMAT)?The PostOut of 7 analysts covering LeMaitre Vascular (NASDAQ:LMAT), 7 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. LeMaitre Vascular has been the topic of 19 analyst reports since July 29, 2015 according to StockzIntelligence Inc ...
04/25/16 07:16 AMLeMaitre Vascular, Inc. (NASDAQ:LMAT) Has An Average Rating Of 4.25 - RealistInvestor.com - LeMaitre Vascular, Inc. (NASDAQ:LMAT) Has An Average Rating Of 4.25RealistInvestor.comIn this analysis, the group considers only the most relevant news sources on a daily basis. LeMaitre Vascular, Inc. (NASDAQ:LMAT) has a 0 daily sentiment score for news issued across the internet today. The daily impact score is given on a scale of 1 ...and more »
04/25/16 07:16 AMPerkins Capital Management Inc Lowers stake in LeMaitre Vascular Inc (LMAT) - Market Digest - Perkins Capital Management Inc Lowers stake in LeMaitre Vascular Inc (LMAT)Market DigestLeMaitre Vascular Inc (LMAT) : Perkins Capital Management Inc reduced its stake in LeMaitre Vascular Inc by 0.21% during the most recent quarter end. The investment management company now holds a total of 145,898 shares of LeMaitre Vascular Inc ...Next Weeks Broker Price Targets For LeMaitre Vascular, Inc. (LMAT)Share Trading Newsall 2 news articles »
04/23/16 06:54 AMAnalyst Coverage: LeMaitre Vascular, Inc. (LMAT) - Risers & Fallers - Analyst Coverage: LeMaitre Vascular, Inc. (LMAT)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of LeMaitre Vascular, Inc. (LMAT). The latest broker reports which are currently outstanding on Friday 22nd of April state 0 analysts have a rating of “strong buy”, 0 ...Lemaitre Vascular Incorporated (NASDAQ:LMAT) Shorts Decreased by 11.28% After Short CoveringFranklin Independentall 2 news articles »
04/22/16 07:34 AMLeMaitre Vascular, Inc. (LMAT) Updated Broker Ratings - Risers & Fallers - LeMaitre Vascular, Inc. (LMAT) Updated Broker RatingsRisers & FallersA number of investment brokers have recently updated their price targets on shares of LeMaitre Vascular, Inc. (LMAT). According to the latest broker reports outstanding on Thursday 21st of April, 0 analysts have a rating of “strong buy”, 0 analysts ...
04/19/16 03:52 PMLeMaitre Vascular Will Announce First Quarter 2016 Earnings Results on May 2, 2016 - [at noodls] - BURLINGTON, Mass., April 19, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2016 financial results on Monday, May 2, 2016, after the ...
04/19/16 07:49 AMLemaitre Vascular Incorporated (NASDAQ:LMAT) Shorted Shares Decreased By 11.28% - RiversideGazette.com - Lemaitre Vascular Incorporated (NASDAQ:LMAT) Shorted Shares Decreased By 11.28%RiversideGazette.comThe short interest to Lemaitre Vascular Incorporated's float is 6.23%. The stock increased 1.07% or $0.17 during the last trading session, hitting $16.08. About 96,033 shares traded hands or 5.58% up from the average. LeMaitre Vascular Inc (NASDAQ:LMAT ...
04/17/16 06:24 AMLeMaitre Vascular, Inc. (NASDAQ:LMAT) Ratios & Valuation in Focus - Orygun Business News - LeMaitre Vascular, Inc. (NASDAQ:LMAT) Ratios & Valuation in FocusOrygun Business NewsLeMaitre Vascular, Inc. (NASDAQ:LMAT) of the Medical sector is a highly scrutinized stock when is comes to the firm's valuation and earnings projections. Using the current price over mean EPS estimate before non-recurring items for the fiscal year, the ...and more »
04/14/16 12:00 PMEarnings Watch on LeMaitre Vascular, Inc. (NASDAQ:LMAT) - RiversideGazette.com - Earnings Watch on LeMaitre Vascular, Inc. (NASDAQ:LMAT)RiversideGazette.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) has a consensus earnings per share estimate for the current quarter of $0.1 based on compiled analyst projections. The company is next expected to release earnings on or around 2016-04-26 for the period ending ...
04/13/16 12:50 PMLeMaitre Vascular, Inc. (LMAT) Updated Broker Price Targets - Share Trading News - Web Breaking NewsLeMaitre Vascular, Inc. (LMAT) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of LeMaitre Vascular, Inc. (LMAT). The latest reports which are currently in issue on Wednesday 13th of April state 5 analysts have a rating of “strong buy”, 2 analysts ...Globeflex Capital L P Reduces Position in LeMaitre Vascular Inc (LMAT)Web Breaking NewsLeMaitre Vascular, Inc. (LMAT) Latest Broker CoverageRisers & FallersLemaitre Vascular Incorporated (NASDAQ:LMAT) Shorts Decreased by 14.23% After Short CoveringStock CallerBusiness Standard Tribuneall 6 news articles »
04/12/16 10:48 AMLeMaitre Vascular, Inc. (LMAT) Updated Analyst Coverage - Risers & Fallers - LeMaitre Vascular, Inc. (LMAT) Updated Analyst CoverageRisers & FallersA number of investment brokers have recently updated their price targets on shares of LeMaitre Vascular, Inc. (LMAT). According to the latest broker reports outstanding on Monday 11th of April, 5 analysts have a rating of “strong buy”, 2 analysts “buy ...
About LeMaitre Vascular

LeMaitre Vascular logoLeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic patches, biologic grafts, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, angioscopes and powered phlebectomy devices. The Company develops, manufactures and markets vascular devices to address the needs of vascular surgeons. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: LMAT
  • CUSIP:
Key Metrics:
  • Previous Close: $13.92
  • 50 Day Moving Average: $14.72
  • 200 Day Moving Average: $15.01
  • P/E Ratio: 31.78
  • P/E Growth: 1.67
  • Market Cap: $262.27M
  • Current Quarter EPS Consensus Estimate: $0.48 EPS
Additional Links:
LeMaitre Vascular (NASDAQ:LMAT) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha